Silexion Therapeutics Corp.
04/25/2025 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 25, 2025 |
| Accession Number: | 0001178913-25-001407 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Silexion Therapeutics Corp. published this content on April 25, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on April 28, 2025 at 10:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]